Invention Application
- Patent Title: ENDOGENOUS PLANT EXPRESSION ENHANCER
-
Application No.: PCT/CA2019/050319Application Date: 2019-03-14
-
Publication No.: WO2020181354A1Publication Date: 2020-09-17
- Inventor: LAVOIE, Pierre-Olivier , D'AOUST, Marc-Andre , KATO, Ko , YAMASAKI, Shotaro
- Applicant: MITSUBISHI TANABE PHARMA CORPORATION , MEDICAGO INC. , NATIONAL UNIVERSITY CORPORATION NARA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: 3-2-1, Dosho-machi Chuo-ku, Osaka 541-8505 JP
- Assignee: MITSUBISHI TANABE PHARMA CORPORATION,MEDICAGO INC.,NATIONAL UNIVERSITY CORPORATION NARA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee: MITSUBISHI TANABE PHARMA CORPORATION,MEDICAGO INC.,NATIONAL UNIVERSITY CORPORATION NARA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: 3-2-1, Dosho-machi Chuo-ku, Osaka 541-8505 JP
- Agency: SECHLEY, Konrad et al.
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A01H5/00 ; C07K14/08 ; C07K14/11 ; C12N15/13 ; C12N15/40 ; C12N15/44 ; C12N15/82 ; C12N5/10 ; C12P21/02
Abstract:
An isolated expression enhancer active in a plant, portion of a plant or plant cell, the expression enhancer is provided. The isolated expression enhancer may be selected from the group consisting of nbEPI42 (SEQ ID NO:1); nbSNS46 (SEQ ID NO:2); nbCSY65 (SEQ ID NO:3); nbHEL40 (SEQ ID NO:4); and nbSEP44 (SEQ ID NO:5). Methods for using the isolated expression enhancer are also provided.
Information query
IPC分类:
